Triethylamine → HCID 59605434, compound
Reaction equation
[CH2:1]([C:3]1[N:7]([C:8]2[N:9]=[C:10]([N:24]3[CH2:29][CH2:28][O:27][CH2:26][CH2:25]3)[C:11]3[N:16]=[C:15]([CH2:17][CH:18]4[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]4)[S:14][C:12]=3[N:13]=2)[C:6]2[CH:30]=[CH:31][CH:32]=[CH:33][C:5]=2[N:4]=1)[CH3:2].Cl[C:35]([C:37]([O:40][C:41](=[O:43])[CH3:42])([CH3:39])[CH3:38])=[O:36].CCN(CC)CC>C(Cl)Cl>[CH2:1]([C:3]1[N:7]([C:8]2[N:9]=[C:10]([N:24]3[CH2:25][CH2:26][O:27][CH2:28][CH2:29]3)[C:11]3[N:16]=[C:15]([CH2:17][CH:18]4[CH2:19][CH2:20][N:21]([C:35](=[O:36])[C:37]([O:40][C:41](=[O:43])[CH3:42])([CH3:39])[CH3:38])[CH2:22][CH2:23]4)[S:14][C:12]=3[N:13]=2)[C:6]2[CH:30]=[CH:31][CH:32]=[CH:33][C:5]=2[N:4]=1)[CH3:2]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 5-(2-ethylbenzoimidazol-1-yl)-7-morpholin-4-yl-2-piperidin-4-ylmethylthiazolo[5,4-d]pyrimidine (96 mg, 0.21 mmol), acetic acid 1-chlorocarbonyl-1-methylethyl ester (40 μL, 0.28 mmol) and NEt3 (40 μL, 0.31 mmol) in DCM (1 mL) was allowed to stir at r.t. for 30 min then concentrated in vacuo. The resulting residue was loaded onto an Isolute® SCX-2 cartridge which was washed with MeOH and the product eluted with 2M NH3/MeOH affording Acetic acid 2-{4-[5-(2-ethylbenzoimidazol-1-yl)-7-morpholin-4-ylthiazolo[5,4-d]pyrimidin-2-ylmethyl]piperidin-1-yl}-1,1-dimethyl-2-oxoethyl ester. LCMS (method A): RT 3.19 min [M+H]+ 592.2
Workup
- concentrationthen concentrated in vacuo
- washwas washed with MeOH
- washthe product eluted with 2M NH3/MeOH
Sources & evidence
- ORD record
- ord-5f5662a4549442f2a17927fa7575d182
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08173650B2
Reaction notes
Loading…